Randomized, phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.
| Autor: | Overman, Michael J., Guthrie, Katherine A, Salem, Mohamed E., Pedersen, Katrina Sophia, Kalyan, Aparna, Colby, Sarah, Fakih, Marwan, Gholami, Sepideh, Gold, Philip Jordan, Chiorean, E. Gabriela, Hochster, Howard S., Philip, Philip Agop |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, pTPS784-TPS784, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|